Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: Evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

B. Ramaswamy, W. Fiskus, B. Cohen, C. Pellegrino, D. L. Hershman, E. Chuang, Thehang Luu, G. Somlo, M. Goetz, R. Swaby, C. L. Shapiro, V. Stearns, P. Christos, I. Espinoza-Delgado, K. Bhalla, J. A. Sparano

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: Evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences